Protagenic Therapeutics- Warrants (13/04/2025) Accounts Payable

The latest accounts payable for PTIXW is $1M as of June 2026. That compares with $2.1M in the prior-year period — down 52.0% year over year. Investors often review this figure alongside Protagenic Therapeutics- Warrants (13/04/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PTIXW's accounts payable moved from $2.1M to $1M — a 52.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Protagenic Therapeutics- Warrants (13/04/2025)'s operating scale or balance-sheet position.

A accounts payable figure of $1M for PTIXW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PTIXW's accounts payable ($1M), review year-over-year change from $2.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Protagenic Therapeutics- Warrants (13/04/2025)'s accounts payable against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.